Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis

Abstract Background Long-term antiviral treatments are associated with a significantly lower hepatocellular carcinoma (HCC) incidence in chronic hepatitis B (CHB) patients by reducing HBV DNA concentrations. However, it is still controversial whether antiviral strategies affect HCC development in an...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Ze-Hong Huang, Gui-Yang Lu, Ling-Xian Qiu, Guo-Hua Zhong, Yue Huang, Xing-Mei Yao, Xiao-Hui Liu, Shou-Jie Huang, Ting Wu, Quan Yuan, Ying-Bin Wang, Ying-Ying Su, Jun Zhang, Ning-Shao Xia
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	BMC 2022-03-01
Seri Bilgileri:	BMC Cancer
Konular:	Chronic hepatitis B Hepatocellular carcinoma Entecavir Tenofovir Cirrhosis
Online Erişim:	https://doi.org/10.1186/s12885-022-09413-7
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!